- Home
- PROK vs BMBL Comparison
PROK vs BMBL Comparison
Compare PROK & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | BMBL |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | 1200 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 425.0M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PROK | BMBL |
|---|---|---|
| Price | $2.15 | $3.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | ★ $7.40 | $4.42 |
| AVG Volume (30 Days) | 504.1K | ★ 4.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,000.00 | ★ $1,071,643,000.00 |
| Revenue This Year | $1,010.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.88 |
| 52 Week Low | $0.46 | $2.61 |
| 52 Week High | $7.13 | $8.63 |
Technical Indicators
Market Signals| Indicator | PROK | BMBL |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 67.84 |
| Support Level | $2.09 | $3.31 |
| Resistance Level | $2.58 | $5.96 |
| Average True Range (ATR) | 0.16 | 0.22 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 2.20 | 73.91 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.